[Labeling of beta-endorphin and beta-lipotropin with iodine 125].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6309339)

Published in C R Seances Soc Biol Fil on January 01, 1983

Authors

G Deby-Dupont, A M Reuter, J Joris, Y Vrindts-Gevaert, P Franchimont

Articles by these authors

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17

Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Br J Anaesth (1992) 3.50

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg (1992) 2.96

Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg (1991) 2.62

Polymorphism of protein and polypeptide hormones. Clin Endocrinol (Oxf) (1972) 1.93

Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med (1989) 1.83

Sepsis and serum cytokine concentrations. Crit Care Med (1997) 1.63

High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology (1994) 1.60

In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation (1990) 1.53

Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporos Int (1993) 1.46

Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme. Br J Surg (2014) 1.44

Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis. Vet J (2007) 1.39

In vitro assays of chondrocyte functions: the influence of drugs and hormones. Scand J Rheumatol Suppl (1990) 1.38

Radio-immunoassay of casein in the serum of normal subjects and of patients with various malignancies. Eur J Cancer (1974) 1.38

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]. N Engl J Med (1989) 1.34

Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer. Eur J Cancer (1975) 1.24

1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet (1987) 1.21

The effect of hypothalamic luteinizing hormone releasing hormone (LH-RH) on plasma gonadotrophin levels in normal subjects. Clin Endocrinol (Oxf) (1974) 1.20

Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage (1998) 1.19

Human calcitonin radioimmunoassay in normal and pathological conditions. Eur J Clin Invest (1974) 1.18

The effect of danazol on anterior pituitary function. Fertil Steril (1977) 1.17

Inhibin: from concept to reality. Vitam Horm (1979) 1.13

Bone mineral content and physical activity. Int J Sports Med (1987) 1.09

Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine (1992) 1.06

Homologous radioimmunoassay for human prolactin. Int J Nucl Med Biol (1976) 1.06

Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis. Scand J Rheumatol (1988) 1.06

Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation. Osteoarthritis Cartilage (2008) 1.06

Prevention of postmenopausal bone loss by tiludronate. Lancet (1990) 1.05

Effects of training on exercise-induced muscle damage and interleukin 6 production. Muscle Nerve (1999) 1.05

Mild endotoxaemia and the inflammatory response induced by a marathon race. Clin Sci (Lond) (1997) 1.04

Are similar inflammatory factors involved in strenuous exercise and sepsis? Intensive Care Med (1994) 1.04

Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl (1987) 1.04

Psychological approaches during conscious sedation. Hypnosis versus stress reducing strategies: a prospective randomized study. Pain (1997) 1.00

Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes. Inflamm Res (2003) 1.00

Radioimmunoassay of proteoglycans. J Immunoassay (1984) 1.00

Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime. Mediators Inflamm (1995) 0.99

[Dosage of prolactin in normal and pathological subjects (author's transl)]. Ann Endocrinol (Paris) (1977) 0.98

Changes in the serum levels of the gonadotrophins progesterone and estradiol during the estrous cycle of the guinea pig. Neuroendocrinology (1975) 0.98

Myocellular enzyme leakage, polymorphonuclear neutrophil activation and delayed onset muscle soreness induced by isokinetic eccentric exercise. Arch Physiol Biochem (1996) 0.96

The neuroendocrine thymus: coexistence of oxytocin and neurophysin in the human thymus. Science (1986) 0.96

Measurement of proteoglycans, elastase, collagenase and protein in synovial fluid in inflammatory and degenerative arthropathies. Clin Rheumatol (1985) 0.95

Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions. Br Med Bull (1999) 0.95

[Studies of gonadal function in patients with central diabetes insipidus (author's transl)]. J Neurovisc Relat (1971) 0.95

Relationship between spermatogenesis and serum gonadotropin levels in azoospermia and oligospermia. J Clin Endocrinol Metab (1972) 0.95

Active oxygen species, articular inflammation and cartilage damage. EXS (1992) 0.94

Production of active oxygen species by isolated human chondrocytes. Br J Rheumatol (1993) 0.93

In vivo studies on the mononuclear phagocyte system Fc receptor function in rheumatoid arthritis. Correlations with clinical and immunological variables. J Rheumatol (1985) 0.93

Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone. Eur J Clin Invest (1982) 0.92

Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept (1998) 0.91

[Radioimmunoassay of plasma H. TSH, II. Results in normal subjects and in pathology]. Ann Endocrinol (Paris) (1972) 0.91

Spectral and enzymatic properties of human recombinant myeloperoxidase: comparison with the mature enzyme. Arch Biochem Biophys (1991) 0.91

High molecular weight vasopressin: detection of a large amount in the plasma of a patient. Clin Endocrinol (Oxf) (1985) 0.91

Puberty-related increase in episodic LHRH release from rat hypothalamus in vitro. Endocrinology (1984) 0.91

Variations of the prealbumin in serum and urine of mice, according to strain and sex. Comp Biochem Physiol (1968) 0.91

Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Contraception (1983) 0.91

Ovulation-inhibiting properties of Org OD 14. Reproduccion (1983) 0.91

[Perfection of a technic for rapid radioimmunoassay of gonadotropins]. Ann Biol Clin (Paris) (1973) 0.91

In-vitro evaluation of drugs proposed as chondroprotective agents. Int J Tissue React (1992) 0.90

Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin. N Engl J Med (1977) 0.90

[Hereditary motor neuron disease: the proximal, adult, sex-linked form (or Kennedy disease). Clinical and neuroendocrinologic observations]. J Neurol Sci (1979) 0.90

In vitro and in vivo arachidonic acid conversions into biologically active derivatives are enhanced by uric acid. Biochem Pharmacol (1981) 0.90

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin. J Bone Miner Res (1994) 0.90

Increase in antioxidant capacity of plasma during propofol anesthesia. J Neurosurg Anesthesiol (1997) 0.89

Increased concanavalin A-binding capacity of immunoglobulin G purified from sera of patients with rheumatoid arthritis. Clin Exp Immunol (1987) 0.89

Defective cytokine expression but adult-type T-cell receptor, CD8, and p56lck modulation in CD3- or CD2-activated T cells from neonates. Pediatr Res (1995) 0.89

Simultaneous assays of cancer associated antigens in benign and malignant breast diseases. Cancer (1977) 0.89

Serum biochemical markers in lung cancer. Br J Cancer (1978) 0.89

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss. Am J Med (1995) 0.89

Oxidant-scavenging activities of beta-lactam agents. Eur J Clin Microbiol Infect Dis (1998) 0.88

Effects of changes in nutritional conditions on timing of puberty: clinical evidence from adopted children and experimental studies in the male rat. Horm Res (1992) 0.88

The thymus as a neuroendocrine organ. Synthesis of vasopressin and oxytocin in human thymic epithelium. Ann N Y Acad Sci (1987) 0.88

The spontaneous ability of normal human IgG to inhibit the Fc receptors of normal human monocytes is related to their binding capacity to lectins. Clin Immunol Immunopathol (1987) 0.88

Immunofluorescent localization of placental lactogen, chorionic gonadotrophin and its alpha and beta subunits in organ cultures of human placenta. Placenta (1981) 0.88

Bilateral neck exploration under hypnosedation: a new standard of care in primary hyperparathyroidism? Ann Surg (1999) 0.88

Pulsatile release of gonadotropin-releasing hormone from hypothalamic explants is restrained by blockade of N-methyl-D,L-aspartate receptors. Endocrinology (1989) 0.88

Novel method for the measurement of cytokine production by a one-stage procedure. J Immunol Methods (1993) 0.88

Simultaneous assays of cancer-associated antigens in various neoplastic disorders. Cancer (1976) 0.88

Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg (1986) 0.88

Effect of several estrogens on serum gonadotropin levels in postmenopausal women. Horm Metab Res (1972) 0.88

Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double-blind placebo-controlled randomised study. Lancet (1985) 0.88

[Gonadotropin secretion in man]. Munch Med Wochenschr (1970) 0.88

Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective? World J Surg (1998) 0.88

The neurohormonal thymic microenvironment: immunocytochemical evidence that thymic nurse cells are neuroendocrine cells. Neuroendocrinology (1988) 0.87

Human chondrocytes in tridimensional culture. In Vitro Cell Dev Biol (1986) 0.87

Natural factors modulating the intervention of activated oxygen in the biosynthesis of prostanoids. Bull Eur Physiopathol Respir (1981) 0.87

Stabilisation of functional tumor necrosis factor-alpha by its soluble TNF receptors. Eur Cytokine Netw (1994) 0.87

Human neurophysine blood levels under normal, experimental and pathological conditions. Clin Endocrinol (Oxf) (1972) 0.87

Radioimmunoassay of human epidermal growth factor in human breast cyst fluid. Eur J Cancer Clin Oncol (1985) 0.86

Effects of propofol on endothelial cells subjected to a peroxynitrite donor (SIN-1). Anaesthesia (2000) 0.86

Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics. Psychoneuroendocrinology (1992) 0.86

Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood. J Vet Diagn Invest (2005) 0.86

Maturation of the hypothalamic control of pulsatile gonadotropin-releasing hormone secretion at onset of puberty. I. Increased activation of N-methyl-D-aspartate receptors. Endocrinology (1990) 0.86

Maturation of the hypothalamic control of pulsatile gonadotropin-releasing hormone secretion at onset of puberty: II. Reduced potency of an inhibitory autofeedback. Endocrinology (1990) 0.86

[Radioimmunological determination of human chorionic somatomammotropin hormone by immunoabsorbent antibodies. Application to clinical obstetrics and research in ectopic hormonal secretions]. Ann Biol Clin (Paris) (1973) 0.86